---

1 2 3 4 5 6 7 8 9 10

читать далее ... es.» Beghe F, Luzzani M. Ann N Y Acad Sci. 1993 Nov 30:698:367-71 4. «Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.» Lahtinen R, Laakso M, Palva I, Virkkunen P, Elomaa I.Lancet. 1992 Oct 31;340(8827):1049-52. 5. "Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.»Luckman SP, Coxon FP, Ebetino FH, Russell RG, Rogers MJ. J. Bone Miner Res. 1998Nov;)3()1):1668-78. 6. «A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PROS Trial).» - Dearnaley DP, Sydes MR, Mason MD, Stott M, Powell CS, Robinson AC, Thompson PM, Moffat LE, Naylor SL, Parmar MK; J NatI Cancer Inst. 2003 Sep 3;95(17):1300-11. 7. «Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.» Fournier P, Boissier S, Filleur S, Guglielmi J, Gabon F, Colombel M, Clezardin P Cancer Res. 2002 Nov 15;62(22):6538-44. 8. «Toxic acute tubular necrosis following treatment with zoledronate (Zometa)» Markowitz GS, Fine PL, Stack Jl, Kunis CL, Radhakrishnan J, Palecki W, Park J, Nasr SH, Hoh S, Siegel DS, D'Agati VD.;Kidney Int. 2003 Jul;64(1):28l-9. 9. «Renal Failure with the Use of Zoledronic Acid» Jennie Т., Lanh G., Julie B. NEJM 2003 Oct., Number 17Volume 349:1676-1679 10. «Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy.» Zhang G, Cai W, Zhou YF, U PW, Gao YJ, Znang Y, Wang SJ, Мао GG, Uu B.Ai Zheng. 2005 Dec;24( 12): 1489-92.Источник: Русаков И.Г., Верещагин Г.В. Русский медицинский журнал. 2006. Т.14. №14. С.1036-1041